Sanofi (SNY) Inventory (2009 - 2026)
Sanofi (SNY) posted Inventory of $12.9 billion for Q2 2026, up 8.78% sequentially from $11.9 billion in Q4 2025, and up 18.8% YoY from $10.9 billion in Q2 2025.
Sanofi (SNY) Inventory (2009 - 2026) Analysis & Trends
Sanofi has reported Inventory for 18 years, with the latest figure at $12.9 billion in Q2 2026.
- Quarterly Inventory rose 18.8% year-over-year to $12.9 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $12.9 billion (up 18.8% YoY) and the FY2025 annual result came in at $11.9 billion, up 17.98% from the prior year.
- Inventory climbed to $12.9 billion in Q2 2026 per SNY's latest filing, from $11.9 billion in the prior quarter.
- Over five years, Inventory peaked at $12.9 billion in Q2 2026 and troughed at $9.1 billion in Q4 2022.
- A 5-year average of $10.8 billion and a median of $10.9 billion in 2023 frame the typical range for Inventory.
- The sharpest annual moves came in 2022 and 2026: Inventory declined 10.39% in 2022, then grew 18.8% in 2026.
- Over 5 years, Inventory stood at $9.1 billion in 2022, then increased by 13.77% to $10.4 billion in 2023, then slipped by 3.1% to $10.1 billion in 2024, then gained by 17.98% to $11.9 billion in 2025, then gained by 8.78% to $12.9 billion in 2026.
- According to Business Quant data, Inventory over the past three periods registered $12.9 billion, $11.9 billion, and $10.9 billion for Q2 2026, Q4 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn | 15.14 Bn |
| 2 | AbbVie | 463.46 Bn | 456.89 Bn | 12.70 Bn | 5.13 Bn |
| 3 | Merck | 367.92 Bn | 360.78 Bn | 12.21 Bn | 6.21 Bn |
| 4 | Novartis Ag | 297.71 Bn | 290.02 Bn | 11.24 Bn | 6.22 Bn |
| 5 | Astrazeneca | 255.55 Bn | 250.65 Bn | 12.86 Bn | 6.93 Bn |
| 6 | Amgen | 234.52 Bn | 220.53 Bn | 7.24 Bn | 6.22 Bn |
| 7 | Gilead Sciences | 178.22 Bn | 175.04 Bn | 6.22 Bn | 1.95 Bn |
| 8 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 9.95 Bn |
| 9 | Gsk | 105.32 Bn | 101.15 Bn | 8.24 Bn | 8.43 Bn |
| 10 | Sanofi | 54.20 Bn | 46.82 Bn | 10.79 Bn | 12.93 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 12.93 Bn |
| Dec 31, 2025 | 11.89 Bn |
| Jun 30, 2025 | 10.89 Bn |
| Dec 31, 2024 | 10.08 Bn |
| Jun 30, 2024 | 11.42 Bn |
| Dec 31, 2023 | 10.40 Bn |
| Jun 30, 2023 | 10.86 Bn |
| Dec 31, 2022 | 9.14 Bn |
| Jun 30, 2022 | 9.99 Bn |
| Dec 31, 2021 | 9.97 Bn |
| Jun 30, 2021 | 11.15 Bn |
| Dec 31, 2020 | 9.96 Bn |
| Jun 30, 2020 | 9.80 Bn |
| Dec 31, 2019 | 660.70 Mn |
| Jun 30, 2019 | 9.46 Bn |
| Dec 31, 2018 | 8.53 Bn |
| Sep 30, 2018 | 150.04 Mn |
| Jun 30, 2018 | 157.53 Mn |
| Mar 31, 2018 | 8.64 Bn |
| Dec 31, 2017 | 8.03 Bn |